Format

Send to

Choose Destination
Neurogenetics. 2016 Jan;17(1):43-9. doi: 10.1007/s10048-015-0466-9. Epub 2015 Nov 17.

De novo missense variants in PPP2R5D are associated with intellectual disability, macrocephaly, hypotonia, and autism.

Author information

1
Department of Pediatrics, Columbia University Medical Center, New York, NY, USA.
2
GeneDx, Gaithersburg, MD, USA.
3
Department of Biochemistry and Molecular Biophysics, Columbia University Medical Center, New York, NY, USA.
4
University of Rochester Medical Center, Rochester, NY, USA.
5
Albany Medical Center, Albany, NY, USA.
6
Valley Children's Hospital, Madera, CA, USA.
7
Division of Pediatric Genetics, University of Michigan Health System, Ann Arbor, MI, USA.
8
Department of Human Genetics, University of Michigan Medical School, Ann Arbor, MI, USA.
9
Departments of Neurology and Pediatrics, University of California San Francisco, San Francisco, CA, USA.
10
Child and Adolescent Neurology Consultants, Sacramento, CA, USA.
11
District Medical Group, Scottsdale, AZ, USA.
12
Department of Pediatrics, Columbia University Medical Center, New York, NY, USA. wkc15@cumc.columbia.edu.
13
Department of Medicine, Columbia University Medical Center, New York, NY, USA. wkc15@cumc.columbia.edu.

Abstract

Protein phosphatase 2A (PP2A) is a heterotrimeric protein serine/threonine phosphatase and is involved in a broad range of cellular processes. PPP2R5D is a regulatory B subunit of PP2A and plays an important role in regulating key neuronal and developmental regulation processes such as PI3K/AKT and glycogen synthase kinase 3 beta (GSK3β)-mediated cell growth, chromatin remodeling, and gene transcriptional regulation. Using whole-exome sequencing (WES), we identified four de novo variants in PPP2R5D in a total of seven unrelated individuals with intellectual disability (ID) and other shared clinical characteristics, including autism spectrum disorder, macrocephaly, hypotonia, seizures, and dysmorphic features. Among the four variants, two have been previously reported and two are novel. All four amino acids are highly conserved among the PP2A subunit family, and all change a negatively charged acidic glutamic acid (E) to a positively charged basic lysine (K) and are predicted to disrupt the PP2A subunit binding and impair the dephosphorylation capacity. Our data provides further support for PPP2R5D as a genetic cause of ID.

KEYWORDS:

Autism spectrum disorder; De novo mutations; Intellectual disabilities; PPP2R5D; Protein phosphatase; Whole-exome sequencing

PMID:
26576547
PMCID:
PMC4765493
DOI:
10.1007/s10048-015-0466-9
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center